Refs Projects IP owners Categories IP Actions
STV13C002 Cytokine Pathway Inhibitor
Tri-specific anti-CXCL monoclonal antibodies as a new agent for cancer treatment. Pleiotropic anti-angiogenic/inflammatory and proliferative–metastatic MOA
INSERM, Université Nice Sophia Antipolis, CNRS Therapeutics

Patent
 Add to my selection   Contact us  Download a PDF file
STV16A001 Anti-Melanoma
New chemical entity for melanoma treatment
INSERM, Université Nice Sophia Antipolis, CNRS Therapeutics

Patent
 Add to my selection   Contact us  Download a PDF file
STV16T001 Triazoles & Cancer
Triazole derivatives to fight myelodysplastic syndromes and acute myeloid leukemia
INSERM, Centre Hospitalier Universitaire de Nice, Université Nice Sophia Antipolis, CNRS Therapeutics

Patent
 Add to my selection   Contact us  Download a PDF file
STV16N002 Kinase inhibitors & cancer
Potentiating anti-PD1 antitumor immunotherapy
INSERM, Centre Hospitalier Universitaire de Nice, Université Nice Sophia Antipolis, CNRS Therapeutics

Patent
 Add to my selection   Contact us  Download a PDF file
STV16A002 Anti-glioblastomas
New Chemical Entities for glioblastoma treatment
INSERM, Université Nice Sophia Antipolis, CNRS Therapeutics

Patent
 Add to my selection   Contact us  Download a PDF file
STV16C002 CD146 mAB & CANCER
IgG monoclonal antibodies targeting Hu sCD146 inhibiting tumor angiogenesis and growth
Aix-Marseille Université, CNRS Therapeutics

Patent
 Add to my selection   Contact us  Download a PDF file

Enter your message

Failure!

Message sent

Your message has been sent

Login

Failure!

Register

You can create a new account here

Register

Failure!

Contact

Failure!

Message sent

Your message has been sent

Type in your email and we will send you a new password